http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445114-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ea17ba87480b776cce77451f86b25bb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
filingDate 2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104f7199ad3fd033e3056252a9953bd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb8cda9773abae916ab1855e3f84706
publicationDate 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2445114-C2
titleOfInvention Composition for treating chronic degenerative inflammatory diseases
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to pharmaceutical industry, particularly to a composition for treating rheumatoid arthritis. Compositions for treating rheumatoid arthritis containing saligenin or Salix ssp extracts, Andrographolide - enriched Andrographis paniculata extract, N-acetyl-glucosamine, and glucuronolactone or glucuronic acid. The use of a combination of saligenin or Salix ssp extracts, and Andrographolide - enriched Andrographis paniculata extract, N-acetyl-glucosamine, and glucuronolactone or glucuronic acid for preparing a drug for treating rheumatoid arthritis. n EFFECT: composition and combination are effective for treating rheumatoid arthritis. n 7 cl, 3 ex
priorityDate 2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005002611-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005074953-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71313401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428402303
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID77065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426132826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589114
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID77065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID175694
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID175694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7067324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5146

Total number of triples: 52.